{
  "ptid_time": "037_S_5126_2019-09-23",
  "img_path": "/data/qiuhui/data/adni/images/037_S_5126/2019-09-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 73,434 mm³, 161.6% above the reference mean. With a Z-score of 3.70 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 6,492 mm³, 8.8% below the reference mean. With a Z-score of -0.80 (21.1th percentile), this represents normal volume ; whole brain volume measures 1,030,740 mm³, 5.8% above the reference mean. With a Z-score of 0.72 (76.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,324 mm³, 9.5% below the reference mean. With a Z-score of -0.58 (28.0th percentile), this represents normal volume ; fusiform gyrus volume measures 18,100 mm³, 6.4% above the reference mean. With a Z-score of 0.58 (72.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,934 mm³, 4.0% above the reference mean. With a Z-score of 0.35 (63.5th percentile), this represents normal volume . ",
  "text_data": "Age is 75.0 years. Gender is Female. Education: 12 years. MMSE: 30.0. MoCA: 28.0. Logical Memory: 20.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.23 SUVR (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "Reasoning: The patient shows profound ventricular enlargement (Z-score 3.70), which is highly suggestive of significant brain atrophy, but hippocampal and other regional volumes are within normal ranges. Cognitive scores (MMSE 30, MoCA 28) are intact, and there is no APOE4 risk allele. Mild AV45 (amyloid) elevation suggests early pathological changes, but clinical symptoms are absent.  \nDiagnosis: Cognitively Normal (CN)  \nConfidence: Medium (due to conflicting imaging and biomarker findings despite normal cognition)",
  "timestamp": "2025-07-26T06:50:01.280242"
}